{"id":"https://openalex.org/W2780997170","doi":"https://doi.org/10.1016/j.bmcl.2017.12.047","title":"Discovery of selective, orally bioavailable inhibitor of mouse chitotriosidase","display_name":"Discovery of selective, orally bioavailable inhibitor of mouse chitotriosidase","publication_year":2017,"publication_date":"2017-12-22","ids":{"openalex":"https://openalex.org/W2780997170","doi":"https://doi.org/10.1016/j.bmcl.2017.12.047","mag":"2780997170","pmid":"https://pubmed.ncbi.nlm.nih.gov/29292229"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2017.12.047","doi":"https://doi.org/10.1016/j.bmcl.2017.12.047","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2017.12.047","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089223533","display_name":"Marzena Mazur","orcid":"https://orcid.org/0000-0002-4766-0482","observed_orcids":["https://orcid.org/0000-0002-4766-0482"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marzena Mazur","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048181811","display_name":"Agnieszka Bartoszewicz","orcid":"https://orcid.org/0000-0002-1534-2690","observed_orcids":["https://orcid.org/0000-0002-1534-2690"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":true,"raw_author_name":"Agnieszka Bartoszewicz","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland. Electronic address: a.bartoszewicz@oncoarendi.com","OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland. Electronic address: a.bartoszewicz@oncoarendi.com","institution_ids":["https://openalex.org/I4210141095"]},{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068551337","display_name":"Barbara Dymek","orcid":"https://orcid.org/0000-0002-1003-2538","observed_orcids":["https://orcid.org/0000-0002-1003-2538"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara Dymek","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065207208","display_name":"Magdalena Salamon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Salamon","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065401757","display_name":"Gleb Andryianau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Gleb Andryianau","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Micha\u0142 Kowalski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Micha\u0142 Kowalski","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070830965","display_name":"Sylwia Olejniczak","orcid":"https://orcid.org/0009-0008-7123-5313","observed_orcids":["https://orcid.org/0009-0008-7123-5313"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Sylwia Olejniczak","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011690284","display_name":"Krzysztof Matyszewski","orcid":"https://orcid.org/0009-0002-5500-0051","observed_orcids":["https://orcid.org/0009-0002-5500-0051"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Krzysztof Matyszewski","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014136520","display_name":"El\u017cbieta Pluta","orcid":"https://orcid.org/0000-0002-6588-8093","observed_orcids":["https://orcid.org/0000-0002-6588-8093"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"El\u017cbieta Pluta","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103116373","display_name":"Bart\u0142omiej Borek","orcid":"https://orcid.org/0000-0003-0117-0354","observed_orcids":["https://orcid.org/0000-0003-0117-0354"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Bart\u0142omiej Borek","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021047504","display_name":"Filip Stefaniak","orcid":"https://orcid.org/0000-0001-5758-9416","observed_orcids":["https://orcid.org/0000-0001-5758-9416"]},"institutions":[{"id":"https://openalex.org/I4210120699","display_name":"International Institute of Molecular and Cell Biology","ror":"https://ror.org/01y3dkx74","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120699"]},{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Filip Stefaniak","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland; Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland","Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland; OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":"https://orcid.org/0000-0001-5758-9416","affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland; Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland","institution_ids":["https://openalex.org/I4210120699","https://openalex.org/I4210141095"]},{"raw_affiliation_string":"Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ks. Trojdena 4, 02-109 Warsaw, Poland; OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210120699","https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027478554","display_name":"Agnieszka Zago\u017cd\u017con","orcid":"https://orcid.org/0000-0001-6200-4355","observed_orcids":["https://orcid.org/0000-0001-6200-4355"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Zagozdzon","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039135976","display_name":"Marcin Mazurkiewicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marcin Mazurkiewicz","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035940553","display_name":"Robert Koralewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Robert Koralewski","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021869363","display_name":"Wojciech Czestkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Wojciech Czestkowski","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037774014","display_name":"Micha\u0142 Piotrowicz","orcid":"https://orcid.org/0000-0001-7214-858X","observed_orcids":["https://orcid.org/0000-0001-7214-858X"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Micha\u0142 Piotrowicz","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084665495","display_name":"Piotr Niedziejko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Piotr Niedziejko","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026883158","display_name":"Mariusz M. Gruza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Mariusz M. Gruza","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062063050","display_name":"Karolina Dzwonek","orcid":"https://orcid.org/0000-0002-9580-3863","observed_orcids":["https://orcid.org/0000-0002-9580-3863"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Karolina Dzwonek","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496114","display_name":"Adam Go\u0142\u0229biowski","orcid":"https://orcid.org/0000-0001-5960-2995","observed_orcids":["https://orcid.org/0000-0001-5960-2995"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Adam Golebiowski","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038751267","display_name":"Jakub Go\u0142\u0105b","orcid":"https://orcid.org/0000-0002-2830-5100","observed_orcids":["https://orcid.org/0000-0002-2830-5100"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]},{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jakub Golab","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland","Department of Immunology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland; Department of Immunology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland","institution_ids":["https://openalex.org/I268303160","https://openalex.org/I4210141095"]},{"raw_affiliation_string":"Department of Immunology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081028300","display_name":"Jacek Olczak","orcid":"https://orcid.org/0000-0001-9932-2373","observed_orcids":["https://orcid.org/0000-0001-9932-2373"]},"institutions":[{"id":"https://openalex.org/I4210141095","display_name":"OncoArendi Therapeutics (Poland)","ror":"https://ror.org/03q2tdj19","country_code":"PL","type":"company","lineage":["https://openalex.org/I4210141095"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jacek Olczak","raw_affiliation_strings":["OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoArendi Therapeutics SA, \u017bwirki i Wigury 101, 02-089 Warsaw, Poland","institution_ids":["https://openalex.org/I4210141095"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5048181811"],"corresponding_institution_ids":["https://openalex.org/I4210141095"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.8475,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.6374283,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"28","issue":"3","first_page":"310","last_page":"314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12683","display_name":"Studies on Chitinases and Chitosanases","score":0.2667999863624573,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.05290000140666962,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chitotriosidase","display_name":"chitotriosidase","score":0.9549999833106995},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.593999981880188},{"id":"https://openalex.org/keywords/enzyme-selectivity","display_name":"enzyme selectivity","score":0.6679999828338623},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8669999837875366},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8769999742507935},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8882453441619873},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.6790300607681274},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.6619335412979126},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6323872208595276},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.4942600727081299},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4743833839893341},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.46906304359436035},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.4651079773902893},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.45261886715888977},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4372686743736267},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.4282240569591522},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4256497621536255},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4073522686958313},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3979327082633972},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.38823631405830383},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3231712579727173},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27030450105667114},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006596","descriptor_name":"Hexosaminidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006596","descriptor_name":"Hexosaminidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2017.12.047","doi":"https://doi.org/10.1016/j.bmcl.2017.12.047","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2017.12.047","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:29292229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29292229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320335039","display_name":"Narodowe Centrum Bada\u0144 i Rozwoju","ror":"https://ror.org/05pwfyy15"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W860297650","https://openalex.org/W1945479327","https://openalex.org/W1971075908","https://openalex.org/W1983671930","https://openalex.org/W1985508669","https://openalex.org/W2000751595","https://openalex.org/W2005361432","https://openalex.org/W2056979046","https://openalex.org/W2060288454","https://openalex.org/W2075254065","https://openalex.org/W2127829790","https://openalex.org/W2133111763","https://openalex.org/W2140475725","https://openalex.org/W2152151486","https://openalex.org/W2159764647","https://openalex.org/W2163201078","https://openalex.org/W2168625934","https://openalex.org/W2490575958","https://openalex.org/W2545839033","https://openalex.org/W2606194456"],"related_works":["https://openalex.org/W3019667912","https://openalex.org/W1997472858","https://openalex.org/W7214121218","https://openalex.org/W2037791377","https://openalex.org/W1997143618","https://openalex.org/W2037169679","https://openalex.org/W2017728873","https://openalex.org/W2004857614","https://openalex.org/W2139908161","https://openalex.org/W2989720134"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-01-05T00:00:00"}